| Gene symbol | MSLN | Synonyms | MPF, SMRP | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mesothelin | ||||
| GTO ID | GTC3759 |
| Trial ID | NCT06256055 |
| Disease | Malignant Mesothelioma | Colorectal Cancer | Bile Duct Cancer | Rectal Cancer | Ovary Cancer | Pancreatic Cancer | Breast Cancer Female |
| Altered gene | MSLN |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UCMYM802 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A First-In-Human, Single Arm, Open-label, Phase 1 Dose-Escalation Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors |
| Year | 2024 |
| Country | China |
| Company sponsor | UTC Therapeutics Inc. |
| Other ID(s) | UCMYM802-Ⅰ |
| Cohort 1 | |||||||||||
|
|||||||||||